Saturday 17 October 2026
Export KRMD’s income statement to Excel — free account
KORU Medical Systems, Inc.
KRMD Healthcare Medical Instruments & Supplies
KORU Medical Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $41.1 million, up 22.2% from fiscal 2024. In the quarter to June 2026, revenue grew 18.2%, EPS grew 222.2%, free cash flow grew 26.2% and total debt fell 50.9%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
3.00
0.03
−0.99%
Follow KRMD
| Feb '17 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 7 | 4 | 2 | 2 | 2 | 5 | 5 | 5 |
P/E ratio |
0.00 | 44.35 | 77.46 | 366.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
8.88 | 20.85 | 27.26 | 60.54 | 41.91 | 17.59 | 8.91 | 7.62 | 9.64 | 14.46 |
P/S ratio |
1.31 | 3.02 | 3.63 | 10.93 | 10.44 | 5.67 | 5.73 | 3.81 | 5.24 | 6.52 |
Altman Z″-Score (non-manufacturers) |
9.41 | 11.57 | 12.64 | 10.36 | 15.74 | 11.95 | 4.08 | 1.18 | (0.54) | (0.06) |
P/FCF ratio |
0.00 | 58.94 | 62.62 | 2,244.86 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | (2.33) | (2.77) | (1.28) | (2.83) | (1.50) | (1.97) | (4.17) | (3.33) | (2.90) |
P/Operating CF |
(40.76) | 99.73 | 496.15 | 307.83 | (147.47) | (185.69) | 119.53 | 98.95 | 187.68 | 245.11 |
P/B ratio |
2.43 | 5.24 | 7.02 | 22.54 | 6.98 | 3.65 | 5.10 | 5.33 | 10.49 | 15.74 |
Price to Tangible BV |
2.60 | 5.59 | 7.55 | 24.28 | 7.15 | 3.73 | 5.23 | 5.54 | 10.96 | 16.40 |
EV/Sales |
1.02 | 2.70 | 3.32 | 10.68 | 9.31 | 4.59 | 5.12 | 3.41 | 4.96 | 6.31 |
EV/EBITDA |
0.00 | 24.06 | 39.12 | 267.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(23.14) | 39.93 | 38.96 | 771.53 | (302.97) | (24.97) | (26.41) | (19.90) | (522.25) | 561.32 |
EV/FCF |
(12.27) | 52.72 | 57.39 | 2,192.84 | (126.56) | (23.02) | (17.39) | (17.06) | (101.02) | (532.53) |
Quick Ratio |
3.78 | 3.85 | 4.22 | 3.78 | 8.15 | 6.19 | 3.15 | 3.49 | 2.16 | 1.88 |
Current Ratio |
4.88 | 5.00 | 5.70 | 4.94 | 10.24 | 7.79 | 4.28 | 4.55 | 2.66 | 2.44 |
Net Debt/EBITDA |
8.77 | (2.84) | (3.57) | (6.34) | 34.27 | 3.86 | 1.67 | 1.19 | 1.69 | 4.07 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.02% | 0.24% | 0.00% | 0.93% | 1.11% | 0.74% | 0.28% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | 0.00 |
Asset Turnover |
1.48 | 1.53 | 1.75 | 1.90 | 0.90 | 0.58 | 0.67 | 0.81 | 1.21 | 1.48 |
Operating CF/Net income |
0.62 | 0.99 | 1.63 | 0.57 | 0.61 | 0.95 | 0.62 | 0.36 | 0.05 | (0.18) |
Capex/Depreciation |
(1.26) | (0.85) | (1.54) | (0.61) | (2.25) | (0.79) | (4.77) | (0.94) | (1.50) | (1.17) |
Interest Coverage |
(387.47) | 426.38 | 41.44 | 7.26 | (29.59) | (536.60) | (74.04) | — | — | — |
| (7.76%) | 12.62% | 10.95% | 5.59% | (5.12%) | (12.56%) | (25.54%) | (53.18%) | (32.64%) | (15.58%) | |
| (6.46%) | 10.37% | 9.19% | 4.62% | (4.51%) | (11.24%) | (20.71%) | (38.82%) | (21.79%) | (9.52%) | |
ROIC |
(14.84%) | 22.52% | 19.65% | 6.82% | (8.78%) | (39.35%) | (47.08%) | (69.86%) | (54.19%) | (22.51%) |
Return on Tangible Assets |
(8.46%) | 12.60% | 10.96% | 5.59% | (3.46%) | (13.57%) | (32.40%) | (69.97%) | (37.40%) | (16.22%) |
Average Days of Receivables |
49.72 | 51.04 | 29.99 | 50.97 | 38.85 | 66.99 | 59.29 | 52.14 | 65.07 | 57.95 |
Research and Development Expense of Revenue |
1.93% | 0.38% | 1.39% | 3.20% | 5.36% | 10.53% | 17.77% | 20.14% | 15.63% | 10.67% |
Selling, General and Administrative Expense of Revenue |
63.18% | 49.53% | 47.23% | 42.19% | 49.75% | 76.04% | 73.87% | 71.41% | 64.29% | 56.84% |
Intangible Assets out of Total Assets |
0.05 | 0.05 | 0.06 | 0.06 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
Share Based Compensation of Revenue |
1.67% | 0.81% | 2.11% | 5.20% | 6.70% | 11.53% | 11.04% | 9.71% | 7.80% | 6.60% |
Graham Net Nets |
0.33 | 0.16 | 0.12 | 0.04 | 0.13 | 0.24 | 0.12 | 0.11 | 0.05 | 0.03 |
Graham Number |
0.00 | 0.33 | 0.34 | 0.34 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(4.07%) | 2.25% | 1.29% | 0.27% | (0.57%) | (3.33%) | (5.63%) | (12.18%) | (3.12%) | (1.11%) |
Free Cash Flow Yield |
(6.36%) | 1.70% | 1.60% | 0.04% | (0.70%) | (3.52%) | (5.14%) | (5.26%) | (0.94%) | (0.18%) |
Revenue per Share |
0.33 | 0.35 | 0.46 | 0.60 | 0.58 | 0.53 | 0.62 | 0.63 | 0.73 | 0.89 |
Operating CF per Share |
(0.01) | 0.02 | 0.04 | 0.01 | (0.02) | (0.10) | (0.12) | (0.11) | (0.01) | 0.01 |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | (0.02) | (0.01) | (0.06) | (0.02) | (0.03) | (0.02) |
Free Cash Flow per Share |
(0.02) | 0.02 | 0.03 | 0.00 | (0.04) | (0.11) | (0.18) | (0.13) | (0.04) | (0.01) |
Cash per Share |
0.09 | 0.11 | 0.14 | 0.15 | 0.65 | 0.57 | 0.39 | 0.25 | 0.21 | 0.19 |
Shareholders Equity per Share |
0.18 | 0.20 | 0.24 | 0.29 | 0.86 | 0.82 | 0.70 | 0.45 | 0.37 | 0.37 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.18 | 0.20 | 0.24 | 0.29 | 0.86 | 0.82 | 0.70 | 0.45 | 0.37 | 0.37 |
Free Cash Flow |
(0.75) | 0.68 | 1.00 | 0.11 | (1.78) | (4.69) | (8.21) | (5.71) | (1.65) | (0.49) |
Working Capital |
5.39 | 6.34 | 7.45 | 9.48 | 33.86 | 32.53 | 22.84 | 15.80 | 11.93 | 11.79 |
Capital Expenditures |
(0.42) | (0.22) | (0.48) | (0.21) | (1.04) | (0.37) | (2.80) | (0.81) | (1.33) | (0.95) |
Net Current Asset Value |
5.29 | 6.32 | 7.45 | 9.24 | 33.76 | 32.53 | 18.80 | 12.15 | 8.73 | 8.84 |
EV/EBIT |
0.00 | 29.06 | 49.51 | 422.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.02 | 0.03 | 0.01 | 0.04 | 0.02 | 0.10 | 0.03 | 0.04 | 0.02 |
Price to Operating Income |
0.00 | 32.49 | 54.02 | 432.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.35 | 0.31 | 0.36 | 0.56 | 0.39 | 0.42 | 0.15 | 0.23 | 0.21 | 0.18 |
Cash ROIC |
(7.28%) | 5.72% | 7.07% | 0.66% | (2.80%) | (7.58%) | (16.70%) | (17.75%) | (6.21%) | (1.87%) |
Accounts Receivable Turnover |
8.13 | 7.53 | 10.56 | 9.94 | 8.33 | 6.82 | 6.31 | 6.63 | 6.68 | 6.57 |
Accounts Payable Turnover |
8.75 | 8.44 | 14.41 | 16.19 | 15.43 | 10.50 | 6.92 | 7.01 | 9.38 | 7.93 |
Inventory Turnover |
3.95 | 3.44 | 3.48 | 3.70 | 2.00 | 1.50 | 2.00 | 2.39 | 3.92 | 4.79 |
Average Days of Payables |
59.68 | 32.05 | 25.30 | 25.16 | 24.68 | 46.09 | 69.69 | 30.14 | 48.91 | 53.32 |
Days of Inventory on Hand |
104.59 | 116.99 | 117.36 | 104.93 | 269.78 | 229.29 | 186.62 | 107.60 | 83.10 | 86.48 |
Average Receivables |
1.51 | 1.77 | 1.64 | 2.33 | 2.90 | 3.44 | 4.42 | 4.30 | 5.04 | 6.26 |
Average Payables |
0.54 | 0.61 | 0.45 | 0.51 | 0.60 | 0.93 | 1.81 | 1.68 | 1.31 | 1.96 |
Average Inventory |
1.20 | 1.51 | 1.88 | 2.25 | 4.61 | 6.47 | 6.26 | 4.94 | 3.14 | 3.24 |
Average Assets |
8.28 | 8.73 | 9.91 | 12.21 | 26.90 | 40.61 | 41.81 | 35.40 | 27.84 | 27.71 |
Average Common Equity |
6.90 | 7.17 | 8.32 | 10.10 | 23.70 | 36.33 | 33.91 | 25.84 | 18.58 | 16.93 |
Columns are period end dates